AKTIS ONCOLOGY

Aktis Oncology is a biotechnology company dedicated to realizing the curative power of alpha radiopharmaceuticals for the mainstream of cancer care... Aktis Oncology is committed to transforming cancer care with novel platform technologies that will enable us to design and develop powerful precision radiopharmaceuticals. These are targeted therapies that safely harness the superior anticancer potency of alpha-emitting particles. Working on a broad set of targets present in commonly occurring cancers, Aktis molecules are poised to revolutionize cancer treatment and impact tumors with currently limited treatment options.

Also known as: Aktis Oncology, Inc.

Primary location: Boston United States